Home > Boards > US OTC > Medical - Drugs > OncBioMune Pharmaceuticals Inc. (OBMP)

The potential market world wide for an ovarian

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
drugmanrx Member Profile
 
Followed By 34
Posts 6,178
Boards Moderated 1
Alias Born 01/23/04
160x600 placeholder
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 5/29/2019 1:09:37 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2019 5:44:06 PM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 5/13/2019 5:16:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/2/2019 5:02:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/30/2019 6:00:54 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/30/2019 6:00:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/30/2019 5:59:44 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/30/2019 5:57:05 PM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 4/30/2019 3:27:08 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/1/2019 4:36:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/19/2019 8:56:51 AM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 3/14/2019 5:59:06 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 3/14/2019 5:54:10 PM
Amended Statement of Beneficial Ownership (3/a) Edgar (US Regulatory) - 3/14/2019 5:53:43 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 3/14/2019 5:51:30 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 3/14/2019 5:48:31 PM
Amended Statement of Beneficial Ownership (3/a) Edgar (US Regulatory) - 3/14/2019 5:47:41 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 3/14/2019 5:46:12 PM
Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 3/6/2019 6:16:40 AM
Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 2/22/2019 5:30:17 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 2/21/2019 5:16:47 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/4/2019 4:27:59 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/29/2019 6:04:22 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/27/2018 3:13:35 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2018 3:56:00 PM
drugmanrx   Tuesday, 05/14/19 10:30:12 AM
Re: learningcurve2020 post# 8559
Post # of 8771 
The potential market world wide for an ovarian cancer vaccine.

In people not dollars.

15-24 years: female 572,229,547)
25-54 years: female 1,488,011,505)
55-64 years: female 322,668,546)
65 years and over: female 352,206,092)

The potential market of high risk males worldwide for a prostate vaccine.

55-64 years: male 307,262,939
65 years and older male 283,540,918

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist